tmorgan@cooley.com
Tess Morgan practices general corporate and securities law, with a focus on emerging growth companies, public companies and capital markets.
Download full bio
Confluent - $828 Million IPO
Opthea – $128 Million IPO
Fastly Agrees to Acquire Signal Sciences for $775 Million
Cardiva Medical Closes $45 Million Financing
Bolt Biotherapeutics – $264.5 Million IPO
Emerging Companies
Capital Markets
Public Companies
Vanderbilt University Law SchoolJD, 2019
Wesleyan UniversityBA, English and French Studies2016
California
Sapphire Ventures Leads Dremio’s $135 Million Series D January 22, 2021
Opthea – $128 Million IPO November 3, 2020
Fastly Agrees to Acquire Signal Sciences for $775 Million August 27, 2020
+1 650 843 5799
Locations